The myelodysplastic syndromes are a group of hematologic disorders that often evolve into secondary acute myeloid leukemia (AML). The genetic changes that underlie progression from the myelodysplastic ...
Relapsed acute myeloid leukemia (AML) is when cancer returns after a period of remission. Refractory AML means cancer has not responded to multiple rounds of treatment. Both can affect your treatment ...
Defining the Role of Donor Lymphocyte Infusion in High-Risk Hematologic Malignancies Current data highlight the potential role for immunotherapy in AML. Gaps in knowledge include limited studies on ...
A person living with acute myeloid leukemia (AML) achieves remission when treatment successfully removes most of the leukemia blast cells from the bone marrow and blood. This is the goal of treatment.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results